← Back

Amino Collective

Europe HQSolo GP Pre-seed Seed
Latest fund: €30M✓ Community-verified
Cheque range
£200k+
Stages
Pre-seed, Seed
Avg deals / year
3.0
Leads rounds
No
HQ
London
Fund type
Solo GP

01 · Thesis & focus

Amino Collective is a health and bio venture firm founded in 2020 by Manuel Grossmann. It is based in Berlin, has an office in London, and is run as a solo-GP fund. It backs pre-seed and seed founders in computational and synthetic biology, AI drug discovery and digital health, mainly in Europe with some US deals. Fund I was €10M and Fund II closed at €30M.

Sectors (3)

02 · Recent publicly announced deals

Sensible Biotechnologies Series A · Oct 2026 · $45M total raised site ↗

Sensible Biotechnologies offers a cell-based mRNA design and manufacturing platform that focuses on producing pure, low immunogenicity mRNA, addressing the limitations of synthetic mRNA. The platform leverages advanced computational technologies in collaboration with NVIDIA to enhance the design and

Founders: Marian K., Miroslav G.
Calibre 🇬🇧 Pre-seed · Apr 2026 · £2.4M First-cheque stage announcement ↗ site ↗

London healthtech offering a health membership that combines clinicians, diagnostics and causal AI to build personalised health plans. Amino Collective led the round.

Founders: Alexander W., Reinhold I., Ben L.
Modern Relay 🇺🇸 Seed · Apr 2026 · $3M First-cheque stage announcement ↗

AI and enterprise software infrastructure / database startup (Tracxn lists its location as the United States).

Founders: Ragnor C., Aaron G.

03 · Similar firms

Raising? See which European funds fit your round →